GlcCer (d18:1/18:0), CAS [[95119-86-1]]

Catalog Number: MCE-HY-170035
Article Name: GlcCer (d18:1/18:0), CAS [[95119-86-1]]
Biozol Catalog Number: MCE-HY-170035
Supplier Catalog Number: HY-170035
Alternative Catalog Number: MCE-HY-170035-5MG,MCE-HY-170035-1MG,MCE-HY-170035-10MG,MCE-HY-170035-25MG
Manufacturer: MedchemExpress
Category: Biochemikalien
Alternative Names: C18 Glucosyl(beta) ceramide (d18:1/18:0), D-glucosyl-beta-1,1 N-stearoyl-D-erythro-sphingosine
GlcCer (d18:1/18:0) (C18 Glucosyl(beta) ceramide (d18:1/18:0)) is a glycosphingolipids that activates the Wnt/beta-catenin pathway by targeting LRP6. GlcCer (d18:1/18:0) drives EMT, migration, invasion and GBA1-mediated liver cancer metastasis. GlcCer (d18:1/18:0) accumulates to impair lysosomal function and induce toxic alpha-synuclein aggregation. GlcCer (d18:1/18:0) supports growth, sporulation, germination and virulence in Penicillium digitatum. GlcCer (d18:1/18:0) is reduced in demyelinated mouse corpus callosum. GlcCer (d18:1/18:0) can be used for the research of liver cancer, synucleinopathies, fungal, Parkinsons disease and Gaucher disease[1][2][3][4][5].
Molecular Weight: 728.09
Purity: 99.93
CAS Number: [95119-86-1]
Formula: C42H81NO8
Target: Fungal,Wnt,beta-catenin
Application Notes: MCE Product type: Natural Products